Lūbax skin cancer detection app in clinical trials

What is that spot? A question that many of us have worried over. A skin cancer detection app developed by Los Angeles-based Lūbax is being tested with physicians and dermatologists in the US, Australia and the UK as of 4 February, World Cancer Day. It uses image recognition software and algorithms to search a proprietary dermatology image database of over 12,000 diagnosed lesions. Their initial large melanoma clinical trials with Harvard, Stanford, Oxford, and the University of São Paulo showed sensitivity and specificity in detecting large melanomas in patients. According to their website, they are expanding the database and algorithm to include basal and squamous cell carcinomas in addition to amelanotic melanomas. There’s a signup for the clinical trial only for iPhone, but their execs in a news item have met with Samsung. BioSpectrum Asia, release on Biospace.com, startup profile on Gust.com

Categories: Latest News.

Leave a Reply

Your email address will not be published. Required fields are marked *